相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
Lars O. Baumbusch et al.
PLOS ONE (2013)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
Tatiana Popova et al.
CANCER RESEARCH (2012)
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Olafur A. Stefansson et al.
EPIGENETICS (2012)
A DNA Repair Pathway-Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
Josephine Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
Nicolai J. Birkbak et al.
CANCER DISCOVERY (2012)
Chemotherapy in epithelial ovarian cancer
Sandro Pignata et al.
CANCER LETTERS (2011)
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group
Charles A. Kunos et al.
GYNECOLOGIC ONCOLOGY (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Protein localization as a principal feature of the etiology and comorbidity of genetic diseases
Solip Park et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
DNA resection in eukaryotes: deciding how to fix the break
Pablo Huertas
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Ana M. Mendes-Pereira et al.
EMBO MOLECULAR MEDICINE (2009)
Breast cancer susceptibility: current knowledge and implications for genetic counselling
Tim Ripperger et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
Olafur Andri Stefansson et al.
BREAST CANCER RESEARCH (2009)
Haploinsufficiency of DNA damage response genes and their potential influence in human genomic disorders
Mark O'Driscoll
CURRENT GENOMICS (2008)
A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity
Christopher J. Lord et al.
DNA REPAIR (2008)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer
Angela Chetrit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Regulation of DNA double-strand break repair pathway choice
Meena Shrivastav et al.
CELL RESEARCH (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
DNA double-strand break repair: From mechanistic understanding to cancer treatment
Thomas Helleday et al.
DNA REPAIR (2007)
DNA repair pathways in clinical practice: Lessons from pediatric cancer susceptibility syndromes
Richard D. Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
BRCA1 promoter methylation predicts adverse ovarian cancer prognosis
Jing Wang Chiang et al.
GYNECOLOGIC ONCOLOGY (2006)
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas
LA Brown et al.
GYNECOLOGIC ONCOLOGY (2006)
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma
EJ Majdak et al.
CANCER (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Tracing the network connecting BRCA and Fanconi anaemia proteins
AR Venkitaraman
NATURE REVIEWS CANCER (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Clinical experience with topotecan in relapsed ovarian cancer
TJ Herzog
GYNECOLOGIC ONCOLOGY (2003)
Breast and ovarian cancer
R Wooster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Improved survival in women with BRCA-associated ovarian carcinoma
I Cass et al.
CANCER (2003)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
